Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03337009 · ClinicalTrials.gov registry record · NA
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
A NA study of Overdose and Risk Behavior, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 1,004
- Enrollment target
- 1
- Study location
NCT03337009: Active NA study of Overdose and Risk Behavior, sponsored by Kaiser Permanente.
NCT03337009 is a NA study of Overdose and Risk Behavior that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 1,004 participants, above the 188-participant average among 13 other Overdose trials with a reported enrollment target (434% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03337009, a NA study of Overdose and Risk Behavior, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,004 participants
- Enrollment target
- 1
- Study location
Study Summary
In the setting of naloxone standing orders, this study will assess the impact of a targeted, web-based overdose prevention and naloxone intervention for patients prescribed chronic opioid therapy. Outcomes are changes in opioid risk behaviors, naloxone uptake, and knowledge about overdose and naloxone.
Conditions Studied
Interventions
- BEHAVIORAL Naloxone Navigator (NN)
Study Locations (1)
Colorado
- Kaiser Permanente Colorado - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,004 participants |
| Start Date | 2017-12-21 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the registry record for NCT03337009 still lists
NCT03337009 is an interventional study that assigns participants to a tested intervention. Its 1,004 participants enrollment target places it among the larger protocols in the corpus, above the 188-participant average among 13 other Overdose trials with a reported enrollment target (434% higher).
The record links to 2 conditions, with Overdose appearing as the primary indexed condition, and to 1 intervention - of which Naloxone Navigator (NN) is the first listed.
NCT03337009 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03337009 about?
NCT03337009 is a clinical study titled "The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy". In the setting of naloxone standing orders, this study will assess the impact of a targeted, web-based overdose prevention and naloxone intervention for patients prescribed chronic opioid therapy. Outcomes are changes in opioid risk behaviors, naloxone uptake, and knowledge about overdose and naloxo...
What is the current status of trial NCT03337009?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,004 participants. The study started on 2017-12-21. Estimated completion is 2024-06-30.
What conditions does trial NCT03337009 study?
This clinical trial studies the following conditions: Overdose, Risk Behavior.
What interventions are being tested in trial NCT03337009?
The interventions under investigation include: Naloxone Navigator (NN) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03337009?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03337009 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03337009's enrollment target sits among peer trials
1,004 1st of 13 higher than 13 of 13 other Overdose trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overdose trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk
RECRUITING · NA
-
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
ACTIVE NOT RECRUITING · NA
-
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
ACTIVE NOT RECRUITING · NA
-
Evaluation of a Medication Health Center to Promote Opioid Safety
ACTIVE NOT RECRUITING · NA
-
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI